Temperature-controlled Laminar Airflow (TLA) in symptomatic severe asthma – a post hoc analysis of severe exacerbations, quality of life and health economics

Autor: A. J. Chauhan, G. Eriksson, W. Storrar, T. Brown, S. Peterson, F. Radner, L. G. D’Cruz, P. Miller, L. Bjermer

Publikováno v: BMC Pulmonary Medicine, Vol 22, Iss 1, Pp 1-9 (2022)

Abstract Purpose Uncontrolled severe asthma constitutes a major economic burden to society. Add-ons to standard inhaled treatments include inexpensive oral corticosteroids and expensive biologics. Nocturnal treatment with Temperature-controlled Lamin

Externí odkaz: https://doaj.org/article/dcfc787390b84de3a20688181dd987bb

Salbutamol use in relation to maintenance bronchodilator efficacy in COPD: a prospective subgroup analysis of the EMAX trial

Autor: F. Maltais, I. P. Naya, C. F. Vogelmeier, I. H. Boucot, P. W. Jones, L. Bjermer, L. Tombs, C. Compton, D. A. Lipson, E. M. Kerwin

Publikováno v: Respiratory Research, Vol 21, Iss 1, Pp 1-12 (2020)

Abstract Background Short-acting β2-agonist (SABA) bronchodilators help alleviate symptoms in chronic obstructive pulmonary disease (COPD) and may be a useful marker of symptom severity. This analysis investigated whether SABA use impacts treatment

Externí odkaz: https://doaj.org/article/99e7710a1bbd4fefbaecd5c24df2ee4f

CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report

Autor: J. Bousquet, G. L. Onorato, C. Bachert, M. Barbolini, A. Bedbrook, L. Bjermer, J. Correia de Sousa, N. H. Chavannes, A. A. Cruz, E. De Manuel Keenoy, P. Devillier, J. Fonseca, S. Hun, T. Kostka, P. W. Hellings, M. Illario, J. C. Ivancevich, D. Larenas-Linnemann, J. Millot-Keurinck, D. Ryan, B. Samolinski, A. Sheikh, A. Yorgancioglu, I. Agache, S. Arnavielhe, M. Bewick, I. Annesi-Maesano, J. M. Anto, K. C. Bergmann, C. Bindslev-Jensen, S. Bosnic-Anticevich, J. Bouchard, D. P. Caimmi, P. Camargos, G. W. Canonica, V. Cardona, A. M. Carriazo, C. Cingi, E. Colgan, A. Custovic, R. Dahl, P. Demoly, G. De Vries, W. J. Fokkens, J. F. Fontaine, B. Gemicioğlu, N. Guldemond, Z. Gutter, T. Haahtela, B. Hellqvist-Dahl, E. Jares, G. Joos, J. Just, N. Khaltaev, T. Keil, L. Klimek, M. L. Kowalski, I. Kull, P. Kuna, V. Kvedariene, D. Laune, R. Louis, A. Magnan, J. Malva, E. Mathieu-Dupas, E. Melén, E. Menditto, M. Morais-Almeida, R. Mösges, J. Mullol, R. Murray, H. Neffen, R. O’Hehir, S. Palkonen, N. G. Papadopoulos, G. Passalacqua, J. L. Pépin, F. Portejoie, D. Price, B. Pugin, F. Raciborski, F. E. R. Simons, M. Sova, O. Spranger, C. Stellato, A. Todo Bom, P. V. Tomazic, M. Triggiani, A. Valero, E. Valovirta, O. VandenPlas, A. Valiulis, M. van Eerd, M. T. Ventura, M. Wickman, I. Young, T. Zuberbier, A. Zurkuhlen, A. Senn

Publikováno v: Clinical and Translational Allergy, Vol 7, Iss 1, Pp 1-16 (2017)

Abstract A Good Practice is a practice that works well, produces good results, and is recommended as a model. MACVIA-ARIA Sentinel Network (MASK), the new Allergic Rhinitis and its Impact on Asthma (ARIA) initiative, is an example of a Good Practice

Externí odkaz: https://doaj.org/article/72e8b04b2d2f486db75e1281e3812453

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The EUFOREA pocket guide for chronic rhinosinusitis

Autor: P.W. Hellings, W.J. Fokkens, R. Orlandi, G.F. Adriaensen, I. Alobid, F.M. Baroody, L. Bjermer, B.A. Senior, A. Cervin, N.A. Cohen, J. Constantinidis, E. De Corso, M. Desrosiers, Z. Diamant, R.G. Douglas, S. Gane, P. Gevaert, J.K. Han, R.J. Harvey, C. Hopkins, R.C. Kern, B.N. Landis, J.T. Lee, S.E. Lee, A. Leunig, V.J. Lund, B. Manuel-Sprekelsen, J. Mullol, C. Philpott, E. Prokopakis, S. Reitsma, D. Ryan, S. Salmi, G. Scadding, R.J. Schlosser, A. Steinsvik, P.V. Tomazic, E. Van Staeyen, T. Van Zele, O. Vanderveken, A-S. Viskens, D. Conti, M. Wagenmann

Publikováno v: Hellings, P W, Fokkens, W J, Orlandi, R, Adriaensen, G F, Alobid, I, Baroody, F M, Bjermer, L, Senior, B A, Cervin, A, Cohen, N A, Constantinidis, J, De Corso, E, Desrosiers, M, Diamant, Z, Douglas, R G, Gane, S, Gevaert, P, Han, J K, Harvey, R J, Hopkins, C, Kern, R C, Landis, B N, Lee, J T, Lee, S E, Leunig, A, Lund, V J, Manuel-Sprekelsen, B, Mullol, J, Philpott, C, Prokopakis, E, Reitsma, S, Ryan, D, Salmi, S, Scadding, G, Schlosser, R J, Steinsvik, A, Tomazic, P V, Van Staeyen, E, Van Zele, T, Vanderveken, O, Viskens, A-S, Conti, D & Wagenmann, M 2022, ' The EUFOREA pocket guide for chronic rhinosinusitis ', Rhinology . https://doi.org/10.4193/Rhin22.344
Rhinology

Chronic rhinosinusitis (CRS) is known to affect around 5 % of the total population, with major impact on the quality of life of those severely affected (1). Despite a substantial burden on individuals, society and health economies, CRS often remains

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88bd948b85622b1ab4d901e8b1143af6
https://www.pure.ed.ac.uk/ws/files/318628756/The_EUFOREA_pocket_guide_for_chronic_rhinosinusitis.pdf